Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
K36 Therapeutics, Inc.
Varian, a Siemens Healthineers Company
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
University of California, Irvine
Blue Earth Therapeutics Ltd
RenJi Hospital
The Netherlands Cancer Institute
Queen Mary University of London
Pathos AI, Inc.
British Columbia Cancer Agency
Ottawa Hospital Research Institute
Marengo Therapeutics, Inc.
University of California, Irvine
Endocyte
Stanford University
Algemeen Ziekenhuis Maria Middelares
VA Greater Los Angeles Healthcare System
Mabwell (Shanghai) Bioscience Co., Ltd.
University of Toronto
Universitaire Ziekenhuizen KU Leuven
Sheba Medical Center